Cinclus Pharma Holding AB (publ) (STO:CINPHA)

Sweden · Delayed Price · Currency is SEK

11.82

0.00 (0.00%)

At close: Aug 14, 2026

Cinclus Pharma Holding AB Financials Overview

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	67.51	57.47	4.58	5.96	10.57	-
Revenue Growth	1373.93%	1154.80%	-23.14%	-43.63%	-	-
Gross Profit	67.51	57.47	4.58	5.96	10.57	-
Operating Income	-241.52	-198.18	-168.93	-200.28	-210.73	-84.27
Net Income	-239.07	-183.97	-168.03	-215.12	-249.07	-76.27
Earnings Per Share	-5.14	-3.95	-4.54	-8.20	-10.81	-3.62
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
China	4.61	4.58	5.96	10.57
Czech Republic	52.86	-	-	-
Total	57.47	4.58	5.96	10.57

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	475.85	487.25	566.72	87.97	173.55	138.2
Total Debt	52.93	7.9	0.3	131.03	0.54	1.46
Net Cash (Debt)	422.92	479.36	566.42	-43.06	173	136.75
Net Cash Growth	-19.21%	-15.37%	-	-	26.51%	-34.41%
Net Cash Per Share	9.09	10.29	15.29	-1.64	7.51	6.48

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-128.5	-74.65	-178.37	-209.19	-192.08	-75.35
Capital Expenditures	-1.16	-1.13	-	-	-	-0.13
Free Cash Flow	-129.65	-75.78	-178.37	-209.19	-192.08	-75.48
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	-
Operating Margin	-357.77%	-344.84%	-3688.45%	-3360.98%	-1993.45%	-
Pretax Margin	-353.86%	-319.66%	-3652.42%	-3601.49%	-2185.32%	-
Profit Margin	-354.14%	-320.12%	-3668.80%	-3609.97%	-2356.20%	-
FCF Margin	-192.06%	-131.86%	-3894.48%	-3510.42%	-1817.01%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	8.15	15.60	217.24	-	-	-